The Winchester Center for Lung Disease will feature 30 exam, consultation and procedure rooms, along with negative-pressure ventilation for infection control purposes.
The outpatient center will house subspecialty programs from Yale’s section of pulmonary, critical care and sleep medicines, including chronic obstructive pulmonary disease, cystic fibrosis and post-COVID-19 pulmonary disease.
“We have over 55 physicians who are known nationally and internationally for their expertise, excellence, and innovation, but access to our clinics has been limited because of space,” section chief Naftali Kaminski, MD, the Boehringer-Ingelheim endowed professor of internal medicine at Yale, said in a news release. “The 6 Devine Street location will allow us to dramatically augment the timeliness of our care, improving the health of patients with lung disease.”
More articles on patient safety and outcomes:
Nearly 50% of women get inappropriate antibiotic prescriptions for UTI, study finds
COVID-19 death risk 64% higher for UK variant, study suggests
10 top patient safety concerns for 2021, ranked by ECRI Institute
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit